Directors Talk – Cadence Minerals #KDNC crystallising value for shareholders

Cadence Minerals plc (LON:KNDC) CEO Kiran Morzaria joins DirectorsTalk Interviews to discuss the macro picture for commodities and Cadence investments, including EMH, BCN, Lithium Australia and the lithium price going forward. We also look at the effects of the macro environment on BCN and EMH, progress made, plans for the JV with Lithium Australia, iron […]

Cadence Minerals #KDNC – Directors Talk Interview with CEO Kiran Morzaria

Cadence CEO Kiran Morzaria joins Directors Talk to discuss the latest developments across the group projects, specifically focusing on the group’s flagship Amapa Iron Ore Project. Kiran provides an overview of the company, and explains the project strategy, shipping of the existing iron ore stockpile, and the final project step that will see Cadence acquire […]

Directors Talk – Interview with Cadence Minerals CEO Kiran Morzaria

An exclusive Directors Talk interview with Kiran Morzaria, CEO of Cadence Minerals #KDNC. In this exclusive 15 minute video interview, Kiran discusses Cadence Minerals ongoing projects and strategy. He explains the spread of minerals and commodities, market performance, driving value for shareholders and the Amapa Iron Ore project.

Radiation for Mesothelioma: Could Proton Therapy Be the Answer? – Advanced Oncotherapy #AVO

Researchers at the Maryland Proton Therapy Treatment Center say that a highly-targeted version of proton beam radiation could be the future of radiotherapy for malignant plural mesothelioma. Advanced Oncotherapy #AVO, is developing a unique, fully integrated, proton therapy system. The LIGHT System is expected to be the first commercially available linear proton accelerator for medical treatment […]

Advanced Oncotherapy (AVO) Chief Ops Officer Ed Lee Q&A with Directors Talk

Advanced Oncotherapy plc (LON:AVO) Chief Operating Officer Ed Lee talks to DirectorsTalk about his background, what that experience brings to AVO and how that knowledge can translate into shareholder value. Transcript below or read on the Directors Talk website here Q1: Ed, thank you for taking time to speak with us. I understand you joined […]

DirectorsTalk – Q&A with Professor Steve Myers at Advanced Oncotherapy (AVO).

Advanced Oncotherapy PLC (LON:AVO) subsidiary ADAM S.A. Executive Chairman professor Steve Myers talks to DirectorsTalk about the LIGHT system, it’s likely impact, the design, the progress being made and its future. Q1: Professor Myers, you became Executive Chairman of ADAM S.A. (ADAM), the CERN spin-off and Advanced Oncotherapy’s (AVO’s) subsidiary, in late 2015, and joined AVO’s […]